BIOMAT Database Logo BIOMAT Database Logo

[Mucocutaneous lymph node syndrome (Kawasaki disease) in adults]. 1982

E Horstmann, and H Daweke

UI MeSH Term Description Entries
D008206 Lymphatic Diseases Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS. Lymphatism,Status Lymphaticus,Disease, Lymphatic,Diseases, Lymphatic,Lymphatic Disease
D009080 Mucocutaneous Lymph Node Syndrome An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities. Kawasaki Disease,Lymph Node Syndrome, Mucocutaneous,Kawasaki Syndrome
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

E Horstmann, and H Daweke
Mucocutaneous lymph node syndrome (Kawasaki disease) in adults.
April 1980, JAMA,
E Horstmann, and H Daweke
Mucocutaneous lymph node syndrome (Kawasaki disease) in adults.
August 1979, JAMA,
E Horstmann, and H Daweke
[Kawasaki disease (mucocutaneous lymph node syndrome)].
December 1987, Ceskoslovenska patologie,
E Horstmann, and H Daweke
Mucocutaneous lymph node syndrome (Kawasaki disease).
September 1976, The Journal of infectious diseases,
E Horstmann, and H Daweke
[Mucocutaneous lymph node syndrome (Kawasaki disease)].
January 1986, Srpski arhiv za celokupno lekarstvo,
E Horstmann, and H Daweke
Mucocutaneous lymph node syndrome (Kawasaki disease).
May 1989, Oral surgery, oral medicine, and oral pathology,
E Horstmann, and H Daweke
[Mucocutaneous lymph node syndrome, Kawasaki disease].
August 1978, Nederlands tijdschrift voor geneeskunde,
E Horstmann, and H Daweke
[Mucocutaneous lymph node syndrome or Kawasaki disease].
November 1981, Revista clinica espanola,
E Horstmann, and H Daweke
[Kawasaki disease (mucocutaneous lymph node syndrome in children)].
April 1983, Pediatriia,
E Horstmann, and H Daweke
[Kawasaki syndrome. Mucocutaneous lymph node syndrome].
September 1983, Die Medizinische Welt,
Copied contents to your clipboard!